Document is current
Any future updates will be listed below
-
Authors
O’Shaughnessy, Joyce
Robert, Nicholas
Annavarapu, Srinivas https://orcid.org/0000-0003-0976-9177
Zhou, Jie
Sussell, Jesse
Cheng, Anna
Fung, Anita
-
Funding
Funding for this research was provided by:
Genentech
- License Information
-
More Information
Article History
Received: 9 November 2020
Accepted: 5 February 2021
First Online: 1 March 2021
Compliance with ethical standards
:
: Dr. Robert is an employee of McKesson and has been a consultant for Bristol-Myers Squibb, Roche, Advi, Boehringer-Ingelheim, New Century Health, and Side-Out Foundation. Dr. O’Shaughnessy reports the following: Honoraria—Abbvie; Agendia; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Eisai; Genentech; Genomic Health; GRAIL; HERON; Immunomedics; Ipsen; Jounce Therapeutics; Lilly; Merck; Myriad Pharmaceuticals; Novartis; Ondonate; Pfizer; Puma Biotechnology; Roche; Samsung; Sanofi; Seattle Genetics; Syndax. Consulting or Advisory Role—Abbvie; Agendia; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Eisai; Genentech; Genomic Health; GRAIL; HERON; Immunomedics; Ipsen; Jounce Therapeutics; Lilly; Merck; Myriad Pharmaceuticals; Novartis; Ondondate; Pfizer; Puma Biotechnology; Roche; Samsung; Sanofi; Seattle Genetics; Syndax. Speakers’ Bureau—AstraZeneca; Lilly; Novartis. Research Funding—Seattle Genetics (Inst). Travel, Accommodations, Expenses—Abbvie; Agendia; Amgen; AstraZeneca; Celgene; Eisai; Genomic Health; GRAIL; Ipsen; Jounce Therapeutics; Lilly; Myriad Pharmaceuticals; Novartis; Pfizer; Puma Biotechnology; Roche; Sanofi; Seattle Genetics; Abbvie; Agendia; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Eisai; Genentech; Genomic Health; GRAIL; HERON; Immunomedics; Ipsen; Jounce Therapeutics; Lilly; Merck; Myriad Pharmaceuticals; Novartis; Ondondate; Pfizer; Puma Biotechnology; Roche; Samsung; Sanofi; Seattle Genetics; Syndax. Srinivas Annavarapu and Jie Zhou are employees of McKesson. Jesse A. Sussell, Anna Cheng, and Anita Fung are employees of Genentech, Inc. and own stock in F. Hoffmann-La Roche.
